Sunjeet S.

Sunjeet S. is an accomplished executive with extensive experience in the biotechnology and oncology sectors. Currently serving as Chief Executive Officer and Board Member at Rappta Therapeutics since September 2021, Sunjeet S. also holds a position as a Member of the Global Board of Advisors at Maroon Invest Global, which focuses on impactful investments in health innovation, particularly in FemTech. Previous roles include Senior Vice President at Ipsen, Vice President at Clovis Oncology, and Managing Director at Baxalta, among others. Sunjeet S. has demonstrated leadership in commercial oncology across multiple regions, including Europe and Asia Pacific, throughout a career that began in clinical research. Educational qualifications include an MSc in Immunology of Infectious Diseases from the London School of Hygiene and Tropical Medicine, a BSc in Genetics from Queen Mary University of London, and a Board Directors Programme in Organizational Leadership from Henley Business School.